Learn More
Apexbio Technology LLC Sarpogrelate hydrochloride 135159-51-2 10mM (in 1mL DMSO)

Supplier: Apexbio Technology LLC B34945.1
Sarpogrelate hydrochloride (CAS 135159-51-2) is a selective antagonist of the 5-HT2A receptor exhibiting a binding affinity (Ki) of 8 39 nM comparable to ritanserin By inhibiting 5-HT2A receptor-mediated pathways sarpogrelate suppresses platelet aggregation thrombus formation and vascular smooth muscle cell proliferation In vitro its primary metabolite (M-1) blocks 5-HT-induced responses at the 5-HT2A receptor with minimal stereoselective difference Clinically oral administration of sarpogrelate in patients with peripheral arterial disease significantly enhances forearm and leg blood flow responses to reactive hyperemia indicating improved vascular function Sarpogrelate is employed in research on platelet function thrombosis and vascular disorders
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.